Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

RLMDRLMD
Showing 5 of 23 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in RELMADA THERAPEUTICS INC

CITADEL ADVISORS LLC holds 1.1M shares of RLMD (RELMADA THERAPEUTICS INC), worth $7.3M as of 2026-Q2. This is a new position. RLMD represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$7.3M

Current Shares

1.1M

Total Value Change

+$7.2M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
1.1M
-
$7.3M0.0%$6.92
38
2026-Q1
Exited
0
-100.0%
$00.0%$4.67
0
2025-Q4
New
28,063
-
$135,5440.0%$4.53
34
2024-Q4
Exited
0
-100.0%
$00.0%$0.46
0
2024-Q3
Decreased
52,846
-37.3%
$171,2210.0%$3.37
0

Other major holders of RLMD: RTW INVESTMENTS, LP, Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used